Helios Bioelectronics Inc.
Update：2026/11/10
Industries
Main Industry
Biotechnology
Main Product/Service
1. CMOS-Based Biochip System
Developed in collaboration with TSMC, the CMOS (Complementary Metal-Oxide-Semiconductor) biochip system is designed for multiplexing, enabling simultaneous detection of multiple biomarkers and rapid collection of extensive bi
Developed in collaboration with TSMC, the CMOS (Complementary Metal-Oxide-Semiconductor) biochip system is designed for multiplexing, enabling simultaneous detection of multiple biomarkers and rapid collection of extensive bi
The content above was translated by Ai
Founded Year
2016
Unified Business No.
45120064
Status
Active
Number of Employees
23
Total Paid-in
Capital
136,302,456 (NT$)
Location of Company
Taiwan
, Hsinchu County
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Helios Bioelectronics Inc. Company IntroductionFounded in 2016, Helios Bioelectronics Inc. is an innovative biotechnology company dedicated to integrating semiconductor technology with biomarker detection.
The company’s initial goal was to combine advanced semiconductor technology with biological diagnostics to develop efficient and precise diagnostic tools, advancing healthcare and drug development. Through collaborations with Taiwan Semiconductor Manufacturing Company (TSMC) and Episil Technologies, Helios has successfully developed two cutting-edge biochip systems, demonstrating its exceptional capability in merging biotechnology with semiconductor technology.
The company’s initial goal was to combine advanced semiconductor technology with biological diagnostics to develop efficient and precise diagnostic tools, advancing healthcare and drug development. Through collaborations with Taiwan Semiconductor Manufacturing Company (TSMC) and Episil Technologies, Helios has successfully developed two cutting-edge biochip systems, demonstrating its exceptional capability in merging biotechnology with semiconductor technology.
The content above was translated by Ai
